Lillie Charisse R has filed 14 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 5 shares of EXELON CORP ($EXC) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Deferred phantom share equivalents | 5 | $49.02 | 3,855.0000 | 1,023,000,000 | 0.13% | 0.00% |
| March 31, 2026 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 878 | $49.82 | 12,554.0000 | 1,023,000,000 | 7.52% | 0.00% |
| Dec. 31, 2025 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 940 | $43.87 | 11,579.0000 | 1,013,000,000 | 8.84% | 0.00% |
| Sept. 30, 2025 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 950 | $43.43 | 10,542.0000 | 1,003,000,000 | 9.90% | 0.00% |
| June 30, 2025 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 954 | $43.25 | 9,505.0000 | 1,003,000,000 | 11.16% | 0.00% |
| March 31, 2025 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 933 | $44.19 | 8,473.0000 | 1,003,000,000 | 12.37% | 0.00% |
| Dec. 31, 2024 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1119 | $36.87 | 7,472.0000 | 1,004,000,000 | 17.61% | 0.00% |
| Sept. 30, 2024 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1025 | $40.23 | 6,288.0000 | 997,000,000 | 19.48% | 0.00% |
| June 30, 2024 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1161 | $35.54 | 5,213.0000 | 997,000,000 | 28.65% | 0.00% |
| March 31, 2024 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1131 | $36.48 | 4,010.0000 | 997,000,000 | 39.28% | 0.00% |
| Dec. 31, 2023 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1052 | $39.21 | 2,849.0000 | 987,000,000 | 58.54% | 0.00% |
| Sept. 30, 2023 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common stock- deferred stock units | 1017 | $40.58 | 1,781.0000 | 987,000,000 | 133.12% | 0.00% |
| June 30, 2023 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Common Stock (Deferred Stock Units) | 758 | $40.08 | 758.0000 | 987,000,000 | 9999.99% | 0.00% |
| June 30, 2023 | EXELON CORP | $EXC | Lillie Charisse R | Director | A | Deferred Compensation - Phantom Share Equivalents | 25 | $40.74 | 3,483.0000 | 987,000,000 | 0.72% | 0.00% |